The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Senescence in tumours: evidence from mice and humans
Open accessAbstract
The importance of cellular senescence, which is a stress response that stably blocks proliferation, is increasingly being recognized. Senescence is prevalent in pre-malignant tumours, and progression to malignancy requires evading senescence. Malignant tumours, however, may still undergo senescence owing to interventions that restore tumour suppressor function or inactivate oncogenes. Senescent tumour cells can be cleared by immune cells, which may result in efficient tumour regression. Standard chemotherapy also has the potential to induce senescence, which may partly underlie its therapeutic activity. Although these concepts are well supported in mouse models, translating them to clinical oncology remains a challenge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“There is little doubt that the senescence growth arrest suppresses the development of cancer (8, 48, 136).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [136]
The cited source says what the claim attributes to it.
In the citing paper
“Other senescence markers have been shown to be overexpressed or activated in cancer152.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“Whatever the case, the examples above, and a growing list of similar studies (Collado and Serrano, 2010), argue that cellular senescence restrains cancer by imposing a cell-autonomous block to the proliferation of oncogenically damaged/stressed cells (Fig. 2).”
From Four faces of cellular senescence (2011) · cites this paper as Collado and Serrano, 2010
In the citing paper
“A SASP profile can be further determined by the activation of molecular cascades linked to p53/p21 (due to persistent double strands breaks/telomere shortening)”
From The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence (2022) · cites this paper as [24]
In the citing paper
“but also to p16/Rb (due to epigenetic modifications) [3,22,24,25,26]”
From The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence (2022) · cites this paper as [24]
In the citing paper
“It is believed that senescence is a key mechanism by which p53 suppresses tumorigenesis (Braig and Schmitt, 2006; Collado and Serrano, 2010).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Collado and Serrano, 2010
In the citing paper
“Therefore, it has been proposed that senescence escape is required for tumor progression to overt malignancy [18,21].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [21]
In the citing paper
“However, senescence has also been implicated both in promoting carcinogenesis 15 and in age-related pathologies 16,17 through its autocrine and paracrine effects, known as the senescence-associated secretory phenotype (SASP) originally described by the Campisi group.18,19”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“More than a decade ago, a phenotype similar to senescence was unexpectedly observed on overexpression of an oncogenic version of HRAS (HRAS G12V ) in normal cells grown in vitro”
BackgroundSelf-citationSenescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“This histone methyltransferase is involved in the formation of heterochromatin and could be relevant for the formation of senescence-associated heterochromatin foci (SAHF), which are domains of silenced chromatin considered important for the senescent phenotyp”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 1×
“Most of the sarcomas, lymphomas and liver carcinomas that developed in the absence of p53 regressed after p53 restoratio”
Background
Research works printed but not linked: 1
- Morton, J. P. et al. Mutant but not knockout p53 drives metastatic pancreatic cancer. Proc. Natl Acad. Sci. USA (in the press).
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Shikama, Y., Yoshida, K., & Shikama, Y. (2026) · BioFactors · doi:10.1002/biof.70087 · Cited by 2
Balancing the Edge: Phosphatases as Homeostatic Buffers of Oncogenic Kinase Signaling in Cancer
Ehm, P. A. H. (2026) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases4010004 · Cited by 2
Aging Triggers an Intestinal Energy Crisis and HDL3 Deficiency Disrupting Gut–Liver Axis Homeostasis
Li, Y., Bao, T., Gao, L., Tian, X., Xue, J., Jin, C., Wang, S., & Wu, X. (2026) · Aging Cell · doi:10.1111/acel.70445 · Cited by 2
Kawamoto, S., Horiguchi, H., Torigoe, D., Wakita, M., Ito, K., Sugawara, S., Zhou, X., Mikawa, T., Park, J. H., Jung, B. K., et al. (2026) · EMBO Reports · doi:10.1038/s44319-026-00740-5 · Cited by 2
“Furthermore, many key genes involved in the induction of cellular senescence are classi fi ed as tumor suppressor genes, suggesting that cellular senescence plays a crucial role in tumor suppression (Collado and Serrano, 2010; He and Sharpless, 2017).”
Hayashi, T. (2013) · Journal of Vaccines & Vaccination · doi:10.4172/2157-7560.s1-002 · Cited by 2
Anti‑tumor properties of FoxO1 in YD‑9 oral squamous cell carcinoma cells
Kim, Y., Seong, C., Cho, K.-A., Lee, S., Kim, T., Kim, H. C., Cho, J., Jung, W. S., Jang, S., Shin, J., et al. (2023) · Oncology Reports · doi:10.3892/or.2023.8559 · Cited by 2
“First, cancer cells sustain autonomous proliferative capacity that is maintained to avoid senescence that can be caused by excessive cell proliferation (5).”
Knopf, P., Pacheco‐Torres, J., Zizmare, L., Mori, N., Wildes, F. B., Zhou, B., Krishnamachary, B., Mironchik, Y., Kneilling, M., Trautwein, C., et al. (2024) · NMR in Biomedicine · doi:10.1002/nbm.5157 · Cited by 2
Non-ionizing radiation-induced cellular senescence and age-related diseases
Wang, H., Tong, J., & Cao, Y. (2024) · Radiation Medicine and Protection · doi:10.1016/j.radmp.2024.04.002 · Cited by 4
Ling, H., Samarasinghe, S., & Kulasiri, D. (2011) · IEEE International Conference on Systems Biology · doi:10.1109/isb.2011.6033112 · Cited by 2
“Most human and mouse tumour cells stop proliferation and undergo senescence at the pre-malignant stage [3] - the second stage of tumorigenesis- where a non-invasive tumour is formed, indicating that the senescence-inducing signals reach sufficient intensity to be effective only in this stage.”
Function of the ING Proteins in Cancer and Senescence
Tran, U., Rajarajacholan, U. K., & Riabowol, K. T. (2013) · Springer eBooks · doi:10.1007/978-94-007-7726-2_18 · Cited by 2
Genetics of Hypertension and Cardiovascular Disease
Katsuya, T., Harrap, S. B., & Ogihara, T. (2010) · International Journal of Hypertension · doi:10.4061/2010/951254 · Cited by 2
Nore1a drives Ras to flick the P53 senescence switch
Donninger, H., & Clark, G. J. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1055050 · Cited by 2
“The detection of RAS-induced senescence in multiple in vitro and in vivo systems confirms that this phenomenon is physiologically relevant.(5) It is now well established that senescence provides a barrier that prevents”
BackgroundTALEN-Induced Translocations in Human Cells
Piganeau, M., Renouf, B., Ghezraoui, H., & Brunet, E. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2932-0_9 · Cited by 2
Ovarian Cancer in Elderly Patients
Freyer, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-23588-2 · Cited by 2
Animal Modeling of Pancreatitis-to-Cancer Progression
Martinelli, P., & Real, F. X. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_66 · Cited by 2
(2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1781-5.00005-2 · Cited by 2
Hallmarks of Cancer: Molecular Underpinnings
Chitale, D. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-93084-4_1 · Cited by 2
Current Model Systems for Investigating Epithelioid Haemangioendothelioma
Neil, E., & Kouskoff, V. (2023) · Cancers · doi:10.3390/cancers15113005 · Cited by 2
“The most common mutation causes inactivation of CDKN2A, which encodes key positive regulators of cell growth arrest and senescence [30,31].”
BackgroundSilva, A. O., Bitencourt, T. C., Vargas, J. E., Fraga, L. R., & Filippi‐Chiela, E. C. (2024) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2023-0311 · Cited by 3
“However, many studies evaluating TIS consider entering senescence as a terminal cell state, neglecting that, despite being non-proliferative, these cells remain metabolically active in the cellular composition of the tumor (Collado and Serrano, 2010).”
BackgroundMethods to Study MYC-Regulated Cellular Senescence
Tabor, V., Bocci, M., & Larsson, L. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-429-6_8 · Cited by 2
Chennappan, S., Schulze, T., & Cirstea, I. C. (2017) · Molecular Life · doi:10.26600/mollife.1.1.1.2017 · Cited by 2
T Cell Senescence and Tumor Immunotherapy
Liu, X., & Peng, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-64597-1_136-1 · Cited by 2
The Connection between Cellular Senescence and Age-Related Diseases
Falandry, C. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316677018.005 · Cited by 2
Čepelak, I., & Dodig, S. (2019) · Rad Hrvatske akademije znanosti i umjetnosti Medicinske znanosti · doi:10.21857/moxpjhglzm · Cited by 2
Thyroid Hormone Receptors and their Role in Cell Proliferation and Cancer
Martínez-Iglesias, O. A., Ruiz-Llorente, L., Contreras‐Jurado, C., & Aranda, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408134-5.00001-9 · Cited by 2
Swanson, E. C. (2014) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2k30f · Cited by 1
Svensson, K. J. (2012) · Lund University Publications (Lund University) · Cited by 2
Predictive Biomarkers of Cellular Radiosensitivity for Clinical Radiotherapy Treatment
White, L. (2016) · Arrow - TU Dublin (Technological University Dublin) · doi:10.21427/d70w2x · Cited by 2
DeSisto, J. A., Lucas, J. T., Xu, K., Donson, A. M., Lin, T., Sanford, B. L., Wu, G., Tran, Q. T., Hedges, D. J., Hsu, C., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/809772 · Cited by 2
Martínez‐Zamudio, R. I., & Herbig, U. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_38-1 · Cited by 2
Mallikarjun, V., Dobre, O., Jackson, M. R., Kidd, M., Llewellyn, J., Gilbert, H. T. J., Richardson, S. M., & Swift, J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.09.511462 · Cited by 3
Chantachotikul, P., Liu, S., Furukawa, K. T., & Deguchi, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.19.553998 · Cited by 2
Klapp, V., Bloy, N., Jiménez‐Cortegana, C., Buqué, A., & Petroni, G. (2023) · Methods in cell biology · doi:10.1016/bs.mcb.2023.02.018 · Cited by 1
Lin, H.-T., Takagi, M., Kubara, K., Yamazaki, K., Michikawa, F., Okumura, T., Naruto, T., Morio, T., Miyazaki, K., Taniguchi, H., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03723-2 · Cited by 1
“The induction of these molecules is consistent with senescence phenotypes, known to be brought by oncogenic RAS expression [47, 48].”
BackgroundGOT2: New therapeutic target in pancreatic cancer
Bu, J., Miao, Z., & Yang, Q. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101370 · Cited by 1
“22,23 Since KRAS ) and combinations of mutation in p53 and p16 24 may allow pancreatic cancer cells to bypass classical senescence pathways, targeting senescence pathways regulated by GOT2 may be important in overcoming therapeutic resistance in pancreatic cancer.”
Tfcp2l1 as a central integrator of hypoxia, dedifferentiation, and tumor progression
Clemente-González, C., & Carnero, A. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03501-9 · Cited by 1
“…and is sometimes associated with tissue aging [48], it is important to note that it is also required by the body to regulate processes such as structure formation during embryonic development, tumor cell elimination, tissue healing, and cellular reprogramming during tissue regeneration [49, 50].”
Li, Q., Zhao, K., Shen, Y., Ying, Q., Chen, B., Zhang, J., Wang, B., Dong, S., & Shi, X. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70220 · Cited by 1
“In premalignant cells, senescence may act as a robust defence mechanism against carcinogenesis (Collado & Serrano, 2010), while in established senescent cells, it can facilitate a pro-tumorigenic microenvironment contributing tumour initiation and metastasis (Ou et al., 2021).”
Selvarani, R., Lee, S., Saminathan, M., Boovalingam, P., Kurup, K., Pham, K., Wolf, R. F., Freeman, W. M., Unnikrishnan, A., & Richardson, A. G. (2025) · GeroScience · doi:10.1007/s11357-025-01994-y · Cited by 1
“…other factors have been shown to trigger cellular senescence in tissues of animals, e.g., oxidative stress (e.g., Sod1 -KO mice [74]), oncogene activation (e.g., TRAS mice [75, 76]) mitochondrial dysfunction (e.g., POLG D257A mice [77]), and epigenetic alterations (e.g., ICE system mice [78]).”
Luo, X., & He, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1848488 · Cited by 1
“It was generally characterized by a stable and essentially irreversible cell-cycle arrest induced by diverse endogenous and exogenous stresses, including telomere attrition, DNA damage, oxidative stress, oncogene activation, and anticancer treatment (27 – 30).”
p16 Beyond Senescence: Cancer Biology Lessons Applied to Endometriosis
Kobayashi, H. (2026) · Reproductive Sciences · doi:10.1007/s43032-026-02134-3 · Cited by 1
“Cellular stresses such as DNA damage, oxidative stress, and oncogene activation activate p53, leading to transcriptional induction of p21 [9 ].”
InfluentialSenescence as a regulatory mechanism in skeletal muscle repair in young mice
Johnson, A., Bevington, R. T., & Parise, G. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00154.2026 · Cited by 1
Zhang, H. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/rqhp-dj51 · Cited by 1
Sénescence et immortalité cellulaire
Trentesaux, C., & Riou, J. (2010) · Bulletin du Cancer · doi:10.1684/bdc.2010.1205 · Cited by 1
When activated oncogene meets immunity: A fight to prevent liver tumor initiation
Nault, J., Amaddeo, G., Zucman‐Rossi, J., Groszmann, R. J., Iwakiri, Y., & Taddei, T. H. (2012) · Hepatology · doi:10.1002/hep.25733 · Cited by 1
“In human carcinogenesis it has been shown that senescent cells, along with apoptotic cells, are more abundant in premalignant lesions (neurofibroma, pancreatic intraductal neoplasias, or colorectal adenomas) than in established malignant tumors.(3) However, given that preneoplastic lesions frequently progress to malig…”
BackgroundLYSYL OXIDASES: EMERGING PROMOTERS OF SENESCENCE ESCAPE, TUMOR INITIATION AND PROGRESSION
Bernard, D. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.10.027 · Cited by 1
Abe, K., Takahashi, A., & Ohira, H. (2016) · Springer eBooks · doi:10.1007/978-4-431-55790-6_2 · Cited by 1
HNSCC Biomarkers Derived from Key Processes of Cancerogenesis
Raudenská, M., Gumulec, J., Fribley, A. M., & Masařík, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-27647-2_7 · Cited by 1
Stress factor – dependent differences in molecular mechanisms of premature cell senescence
Petrova, N. V., Velichko, A. K., Petrova, N. V., Razin, S. V., & Kantidze, O. L. (2015) · Biopolymers and Cell · doi:10.7124/bc.0008f4 · Cited by 1
T Cell Senescence and Tumor Immunotherapy
Liu, X., & Peng, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_136 · Cited by 1
Zebrafish imaging reveals hidden oncogenic–normal cell communication during primary tumorigenesis
Haraoka, Y., Miyake, M., & Ishitani, T. (2023) · Cell Structure and Function · doi:10.1247/csf.23026 · Cited by 1
“Previous studies using mammalian models have shown that cellular senescence suppresses tumorigenesis through two mechanisms (Collado and Serrano, 2010; Gorgoulis et al. , 2019): the induction of permanent cell cycle arrest in oncogenic cells ( Fig.”
BackgroundHafner, C. M., & Hartmann, A. (2010) · Der Pathologe · doi:10.1007/s00292-010-1332-z · Cited by 1
Mad2 and BubR1: chemotherapeutic coordinators in gastric cancer
Iimori, M., Kitao, H., & Maehara, Y. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1018051 · Cited by 1
Induction of Cancer Cell Senescence: Role of Caffeic Acid 3,4-Dihydroxy-Phenethyl Ester
Luo, J., Tang, X., & Dong, A. (2014) · Springer eBooks · doi:10.1007/978-94-017-9325-4_4 · Cited by 1
Ueda, A., Yoneda‐Kato, N., Yamanaka, Y., Nakamae, I., & Kato, J. (2016) · Journal of Hematology and Oncology Research · doi:10.14302/issn.2372-6601.jhor-16-1125 · Cited by 1
“Senescence has been recognized as a part of the system that prevents the tumorigenic transformation of mammalian cells [1,2] by inhibiting cell proliferation, and eliminates damaged cells via an inflammatory process by affecting surrounding cells through secreted factors [6] .”
Detection of the Ubiquitinome in Cells Undergoing Oncogene-Induced Senescence
Zhu, H., Le, L., Tang, H., Speicher, D. W., & Zhang, R. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_12 · Cited by 1
Animal Modeling of Pancreatitis-to-Cancer Progression
Martinelli, P., & Real, F. X. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_66-1 · Cited by 1
Gholipour, N., Mashjoor, S., Tubkanlu, Z. E., Khajeh, H., Naderi, M., Samaei, N. M., & Motalleb, G. (2018) · Bioscience Journal · doi:10.14393/bj-v34n5a2018-42617 · Cited by 1
A framework for addressing senescent cell burden in the osteoarthritic knee
Chin, A. F., Han, J., Gray-Gaillard, E. F., Michel, J. H., & Elisseeff, J. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00010-9 · Cited by 2
Muro‐Cacho, C. (2015) · John Wiley & Sons, Inc. eBooks · doi:10.1002/9781118834015.ch107 · Cited by 1
Thyroid Hormone Receptors and their Role in Cell Proliferation and Cancer
Martínez-Iglesias, O. A., Ruiz-Llorente, L., Contreras‐Jurado, C., & Aranda, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819801-8.00011-9 · Cited by 1
Hypoxia and Senescence: Role of Oxygen in Modulation of Tumor Suppression
Eren, M. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-0313-9_5 · Cited by 1
Dimri, M., & Dimri, G. P. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0025372 · Cited by 1
Ling, H. (2011) · Lincoln University Research Archive (Lincoln University) · Cited by 2
Tecleab, A. (2013) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1
Sedivy, J. M., & van Deursen, J. M. (2013) · Longevity & Healthspan · doi:10.1186/2046-2395-2-7 · Cited by 1
“Recent data have implicated cellular senescence as an important in vivo tumor suppression mechanism [11].”
BackgroundToll-like receptor 2 orchestrates a potent anti-tumor response in non-small cell lung cancerPreprint
Millar, F. R., Pennycuick, A., Muir, M., Quintanella, A., Hari, P., Freyer, E., Gautier, P. E., Meynert, A. M., TEIXEIRA, V. H., Connelly, J. C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.04.446876 · Cited by 1
“J Immunol 708 2016;197(11):4493-503 doi 10.”
BackgroundChen, J.-Y., Hug, C. B., Reyes, J. S., Tian, C., Gerosa, L., Fröhlich, F., Ponsioen, B., Snippert, H. J. G., Spencer, S. L., Jambhekar, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.06.511142 · Cited by 1
“OIS, first reported in primary diploid fibroblasts with HRasG12V expression (Serrano et al., 1997), was later found to be caused by various oncogenes and reported in multiple in vitro cell systems as well as at the organismal level (Collado and Serrano, 2010).”
BackgroundLérida‐Viso, A. (2023) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/194709 · Cited by 1
Mathematical models for tumour invasion
Holder, A. B. (2015) · Research Online (University of Wollongong) · Cited by 1
Active, Dormant, or on the Path to Elimination: What Does a Senescent Cell Do?
Ben‐Porath, I. (2014) · Springer eBooks · doi:10.1007/978-94-017-9325-4_1
Regulation of the Promyelocytic Leukemia Protein and Its Role in Premature Senescence
Lau, A. W., Tron, A. E., & Wei, W. (2014) · Springer eBooks · doi:10.1007/978-94-017-9325-4_9
Caveolar Vesicles in Cellular Senescence
Wheaton, K. (2012) · InTech eBooks · doi:10.5772/31976
“In addition to this evidence it has become increasingly apparent that senescence is a natural barrier to oncogenic transformation in many different tumour types (Collado and Serrano, 2010).”
Chong, K. H. (2014) · Lincoln University Research Archive (Lincoln University)
Velasco-Hernández, T. (2011) · Gredos (University of Salamanca) · doi:10.14201/gredos.110634
Renal Aging and Kidney Transplantation
De, K., & Naesens, M. (2013) · InTech eBooks · doi:10.5772/55469
Zapperi, S., & Porta, C. A. M. L. (2015) · Wiley eBooks · doi:10.1002/9781118670613.ch15
ENFERMEDADES NEURODEGENERATIVAS Y CÁNCER: HIPÓTESIS DE SU RELACIÓN INVERSA EN EL ENVEJECIMIENTO
Dagobeth, E. E. V. (2014) · REVISALUD Unisucre · doi:10.24188/23394072.v2.n1.2014.126 · Cited by 1
Chang, Z. (2011) · Digital Commons-TMC (Texas Medical Center)
The influence of methyl donor status on cervical cancer cell behaviour in vitro
Poomipark, N. (2013) · UPT. Syiah Kuala University Library (Syiah Kuala University)
The Molecular Frame of Pancreatic Carcinogenesis
Heßmann, E., Baumgart, S., Chen, N., Singh, S. K., Singh, G., König, A., Neeße, A., & Ellenrieder, V. (2014) · InTech eBooks · doi:10.5772/57422
“These precursor lesions then exhibit many features of senescence including positive senescence-associated ß-galactosidase staining and induction of cell cycle inhibitors [77].”
Brandhorst, S. (2013) · DuEPublico (University of Duisburg-Essen)
Augmentation of Ras-induced cell transformation : a new role for miR-200a in malignancy.
Becker, L. (2014) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/92
ERBB4 mutations in cancer and amyotrophic lateral sclerosis
Kurppa, K. J. (2014) · UTUPub (University of Turku)
Skommer, J., Raychaudhuri, S., & Włodkowic, D. (2011) · arXiv (Cornell University) · doi:10.48550/arxiv.1101.3251
“cancer cell senescence rather then cell death (24).”
BackgroundMultiple onkogene Mutationen in seborrhoischen Keratosen
Berneburg, M. (2011) · Der Hautarzt · doi:10.1007/s00105-010-2109-2
Translational Control of Cell Proliferation and Viability in Normal and Neoplastic Cells
Avdulov, S. V., Gómez-García, J. R., Bitterman, P. B., & Polunovsky, V. A. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_18
Barakat, D. J., Denmeade, S. R., & Friedman, A. D. (2015) · Defense Technical Information Center (DTIC) · doi:10.21236/ada621015
Non‐Small Cell Lung Cancers (NSCLC) with Mutations inBRAF
Ferrarotto, R., & Simon, G. R. (2014) · Lung Cancer · doi:10.1002/9781118468791.ch36
Zamin, L. L. (2010) · Americanae (AECID Library)
Fulmer, T. (2010) · Science-Business eXchange · doi:10.1038/scibx.2010.362
Senescence Escape in Melanoma: Role of Spleen Tyrosine Kinase SYK
Deckert, M., & Tartare‐Deckert, S. (2013) · Springer eBooks · doi:10.1007/978-94-007-7726-2_22
Mitochondrial DNA mutations. Brain developmental and ageing consequences, and possible treatments
Ross, J. M. (2012) · Figshare
Degerman, S. (2010) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
CellsSurveillance of Unhealthy Cells by Natural Killer
Iannello, A., & Raulet, D. H. (2013)
Role of SIRT6 in Metabolic Reprogramming During Colorectal Carcinoma
Sebastián, C. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada614181
The primary cilium as a regulator of cellular senescence in human fibroblasts
Breslin, L. (2014) · ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) · doi:10.13025/17764
The effect of radiation on cellular ageing
Sabin, R. J. (2012) · Brunel University Research Archive (BURA) (Brunel University London)
Costa, J. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Gourdon, S., Réguerre, Y., Bubien, V., Pérel, Y., Doray, B., Lacombe, D., & Ducassou, S. (2016) · Revue d Oncologie Hématologie Pédiatrique · doi:10.1016/j.oncohp.2015.12.003
Metadata
- Authors
- Collado, M., & Serrano, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Venue
- Nature Reviews Cancer
- Published
- 2010-01
- Volume
- 10
- Issue
- 1
- Pages
- 51-57
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3672965
- OpenAlex
- W2087999409
- Cited by
- 1,124
- References
- 58
- Citations by year
- 2026: 34 · 2025: 40 · 2024: 56 · 2023: 73 · 2022: 60 · 2021: 64 · 2020: 47 · 2019: 67 · 2018: 66 · 2017: 66 · 2016: 73 · 2015: 81 · 2014: 104 · 2013: 102 · 2012: 82
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- oncogene-induced senescence, cellular senescence, tumor suppressor function, tumor regression, chemotherapy-induced senescence, senescence therapy, mouse tumor model
- MeSH terms
- Animals, Disease Models, Animal, Humans, Neoplasms, Cellular Senescence, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
